Aminoglycoside
Aminoglycoside is a pharmaceutical drug with 5 clinical trials. Currently 1 active trials ongoing. Historical success rate of 66.7%.
Success Metrics
Based on 2 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
1
Mid Stage
1
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
66.7%
2 of 3 finished
33.3%
1 ended early
1
trials recruiting
5
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Standardizing Treatments for Pulmonary Exacerbations - Aminoglycoside Study
Risk Factors and Machine Learning Model for Aminoglycines Related Acute Kidney Injury
Prosthetic Valve Sweing Ring Injection by Antiboitics Can Affect the Rate of Postoperative Infective Endocarditis?
Safety, Tolerability and Efficacy of Ceftaroline in Paediatrics With Late-Onset Sepsis
Identification of Gene and Protein Markers of Kidney Injury in Aminoglycoside-treated Children
Clinical Trials (5)
Standardizing Treatments for Pulmonary Exacerbations - Aminoglycoside Study
Risk Factors and Machine Learning Model for Aminoglycines Related Acute Kidney Injury
Prosthetic Valve Sweing Ring Injection by Antiboitics Can Affect the Rate of Postoperative Infective Endocarditis?
Safety, Tolerability and Efficacy of Ceftaroline in Paediatrics With Late-Onset Sepsis
Identification of Gene and Protein Markers of Kidney Injury in Aminoglycoside-treated Children
All 5 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 5